Laserwelt has entered into an agreement to distribute Verisante Technology’s non-invasive optical system, designed for the evaluation of skin lesions that may be clinically suspicious for melanoma, squamous cell carcinoma and/or basal cell carcinoma.

Continue reading here:
Laserwelt, Verisante in non-invasive optical system distribution agreement